ACE (ACE) News
Track canonical SquawkNews coverage tagged to ACE, ACE. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 9 indexed stories across 7 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ACE wins Ministry of Defence order for 74 4x4 backhoe loaders
Action Construction Equipment (ACE) has received an order from the Border Roads Organisation (BRO), under the Ministry of Defence, for the supply of 74 4x4 backhoe loaders, the company said in a regulatory filing on Wedn
NEWS | Sep 30, 2026, 10:11 AM UTC
L
Action Construction Equipment shares gain 3% after Defence Ministry order win
Shares of Action Construction Equipment rose 3.04% on September 30 after the company announced an order from the Border Roads Organisation (BRO), Ministry of Defence, for 74 4X4 backhoe loaders.The stock was trading at R
EQUITY | Sep 30, 2026, 09:01 AM UTC
L
Acea Wins $4.5 Mln Wastewater Treatment Contract In Peru
Acea S.p.A. MIL:ACE
NEWS | Sep 24, 2026, 01:15 PM UTC
L
ACE - Ascelia Pharma Announces Publication of Orviglance Clinical Study in Journal of Magnetic Resonance Imaging
ACE - Ascelia Pharma Announces Publication of Orviglance Clinical Study in Journal of Magnetic Resonance Imaging
NEWS | Sep 24, 2026, 05:50 AM UTC
L
Ascelia Pharma completes FDA Type A meeting on Orviglance NDA
Ascelia Pharma completed a previously scheduled Type A meeting with the FDA on September 9, 2026, regarding the Complete Response Letter (CRL) for the Orviglance New Drug Application (NDA). The meeting was held to discus
REGULATION | Sep 10, 2026, 05:45 AM UTC
L
Acusensus enters Victorian road safety camera test sites agreement
Acusensus Ltd has entered into Victorian road safety camera test sites agreement.
EQUITY | Sep 02, 2026, 11:45 PM UTC
L
Back To The Drawing Board: Which Drugs Received Complete Response Letters From The FDA In July?
SEOUL (dpa-AFX) - The biotechnology sector is a high-risk investment arena, and investing in these companies requires considerable patience. Drug developers can spend years - even decades - and billions of dollars bringi
REGULATION | Sep 01, 2026, 01:12 PM UTC
L
ACE - Focus on The Path Forward for Orviglance
ACE - Focus on The Path Forward for Orviglance
EQUITY | Aug 20, 2026, 05:50 AM UTC
M
Ascelia Pharma FDA schedules Type A meeting for Orviglance NDA Sep 9, 2026
Ascelia Pharma says the FDA has scheduled a Type A meeting for its Orviglance NDA on September 9, 2026.
REGULATION | Aug 17, 2026, 10:10 AM UTC